Hyperglycemia impairs macrophage and neutrophil function, decreases IFN-γ and IL-12 signaling, and blunts Th1 responses leading to 2–3-fold higher reactivation risk [21–23]. This evidence concerns the gene IFNG and Hyperglycemia.